Broadway Gold Mining Ltd. Stock

Equities

BRD

CA11144V1058

Delayed Toronto S.E. Other stock markets 10:56:01 2019-07-05 am EDT			5-day change	1st Jan Change
0.075 ^CAD	-6.25%		-6.25%	-.--%

2020	Mind Medicine Inc. (‘MMED’) completed the acquisition of Broadway Gold Mining Ltd. (‘Broadway’) in a reverse merger transaction.	CI
2020	Broadway Gold Mining Ltd. completed the spin-off of Madison Metals Inc.	CI

on all our subscriptions*

Take advantage of the offer

* See conditions on site

Financials

Sales 2018	-	Sales 2019	-	Capitalization	3.65M 4.99M
Net income 2018	-1M -1.37M	Net income 2019	-1M -1.37M	EV / Sales 2018	-
Net cash position 2018	202K 276K	Net cash position 2019	23.83K 32.58K	EV / Sales 2019	-
P/E ratio 2018	-4.62 x	P/E ratio 2019	-2.31 x	Employees	-
Yield 2018 *	-	Yield 2019	-	Free-Float	0%

More Fundamentals * Assessed data

Chart Broadway Gold Mining Ltd.

Duration

Period

Style

Dynamic Chart

Latest news about Broadway Gold Mining Ltd.

Mind Medicine Inc. (‘MMED’) completed the acquisition of Broadway Gold Mining Ltd. (‘Broadway’) in a reverse merger transaction.	20-02-26	CI
Broadway Gold Mining Ltd. completed the spin-off of Madison Metals Inc.	20-02-26	CI
Broadway Gold Mining Ltd. Reports Earnings Results for the First Quarter Ended November 30, 2019	20-01-28	CI
Broadway Gold Mining Ltd. Reports Earnings Results for the Full Year Ended August 31, 2019	19-12-19	CI
Broadway Gold Mining Ltd. Auditor Raises 'Going Concern' Doubt	19-12-18	CI
Broadway Gold Mining Ltd. cancelled the acquisition of 85% stake in Copper/Vanadium mining camp in Namibia from three unknown sellers.	19-10-14	CI
Mind Medicine Inc. entered into a binding letter of intent to acquire Broadway Gold Mining Ltd. in a reverse merger transaction.	19-07-25	CI
Broadway Gold Mining Ltd. Reports Earnings Results for the Third Quarter Ended May 31, 2019	19-07-25	CI
Broadway Gold Mining Ltd. announced the spin-off of mining assets.	19-07-25	CI
Broadway Gold Mining Ltd. Announces Commencement of Drilling at Madison Copper-Gold Project Located in the Butte Region of Montana	19-06-24	CI
Broadway Gold Mining Ltd. Acquires Copper/Vanadium Mining Camp in Namibia	19-06-03	CI
Broadway Gold Mining Ltd. agreed to acquire 85% stake in Copper/Vanadium mining camp in Namibia from three unknown sellers for $0.22 million.	19-06-02	CI
Broadway Gold Mining Ltd. and Kennecott Exploration Company Sign Earn In with Option to Joint Venture Agreement	19-04-30	CI
Broadway Gold Mining Ltd. Reports Earnings Results for the Second Quarter Ended February 28, 2019	19-04-18	CI
Broadway Gold Mining Ltd. Announces Management Changes	19-04-09	CI

More news

Press releases Broadway Gold Mining Ltd.

Broadway Gold Mining : MindMed's Microdosing Division Further Expands Phase 2 Clinical Trial of Microdosing LSD For Adult ADHD	20-06-02	AQ
Broadway Gold Mining : MindMed Closes Upsized Financing of $13.2m to Advance UHB Liechti Lab Collaboration for Next-Gen Psychedelic Inspired Medicines	20-05-26	AQ
Broadway Gold Mining : MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing	20-05-21	AQ
Broadway Gold Mining : MindMed Reports First Quarter 2020 Results and Corporate Update	20-05-14	AQ
Broadway Gold Mining : MindMed Advances Phase 2 LSD Microdosing Trial For Adult ADHD, Appoints Principal Investigator	20-05-11	AQ

More press releases

News in other languages on Broadway Gold Mining Ltd.

IRW-News: Mind Medicine Mindmed Inc. : Klinische Phase-II-Studie zu LSD bei Suizid-Kopfschmerz: Behandlung der Patienten beginnt	20-06-08
IRW-News: Mind Medicine Mindmed Inc. : MindMed startet mit Projekt Lucy: Empirische LSD-Therapie zur Behandlung von Angststörungen im Fokus	20-06-04
IRW-News: Mind Medicine Mindmed Inc. : MindMeds Geschäftssparte für Mikrodosierung erweitert klinische Phase-II-Studie zur Mikrodosierung von LSD in der Behandlung von Erwachsenen mit ADHS	20-06-02
IRW-News: Mind Medicine Mindmed Inc. : MindMed nimmt MDMA in Pipeline auf, um psychedelische Therapien der nächsten Generation zu entwickeln	20-05-27
IRW-News: Mind Medicines Mindmed Inc. : MindMed, das Pharmaunternehmen für Psychedelika, entwickelt LSD-Neutralisierungstechnologie zur Verkürzung und dem Abbruch von LSD-Trips	20-04-22